About
Synvect develops CRISPR-based gene editing solutions to sterilize mosquito eggs, releasing non-biting sterile male mosquitoes to suppress and reduce populations of disease-carrying mosquitoes.
Explore Synvect's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.